Cancer Family
Immunodeficiency-Related Neoplasm
CI-CAN-00000205Explore in graph →
Non-malignant15 active trials3 approved drugs
- NCIt
- C27936
Loading cancer entity…
Cancer Family
CI-CAN-00000205Explore in graph →
Clinical trials
79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02822495 | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies | no longer available | — | — | Atara BiotherapeuticsINDUSTRY | 0 | Jun 15, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jun 15, 2023source: clinicaltrials